270 Tapering biological therapies: what do patients think?
Claire Holmes(University of Southampton), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Jalaa Zarroug(University Hospital Southampton NHS Foundation Trust), Christopher Holroyd(Southampton General Hospital), Dinny Wallis(University Hospital Southampton NHS Foundation Trust), Kate Sonpal(NIHR Wellcome Trust Southampton Clinical Research Facility), Jo Adams(Cancer Research UK)
Cited by 6
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis
|Annals of the Rheumatic Diseases|2013|668
Vitamin D supplementation in pregnancy: a systematic review
|Health Technology Assessment|2014|353